Back to discover
Drug

Ketorolac

In clinical development
Emerging researchLate-stage development
Also known as Acular, Acuvail, Ketorolac Tromethamine, Omidria+5 more

Acular, Acuvail, Ketorolac Tromethamine, Omidria, Sprix, Toradol, rac-Ketorolac, Ketorolaco, Ketorolacum.

2
Research papers
28
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis

Clinical trial2026-07-01Withdrawn · ClinicalTrials.gov

Non-Narcotic Pain Control After ACL Reconstruction

Clinical trial2026-06-12Primary completion · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Ketorolac
Aliases & brands
AcularAcuvailKetorolac TromethamineOmidriaSprixToradolrac-KetorolacKetorolacoKetorolacum
RxNorm CUI
35827
ChEMBL ID
CHEMBL469
UNII
YZI5105V0L

Clinical trials

195 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
195
registered trials across all phases
LATEST COMPLETION 2026
28
Active studies
26
Recruiting
150
Late-stage (III+)
109
Completed
58
Discontinued
PHASE DISTRIBUTIONn = 195
Early Phase 17Phase 110Phase 1 / 22Phase 226Phase 2 / 37Phase 329Phase 486Phase N / A28

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20232024
Major research themes4
Anti-Inflammatory Agents, Non-Steroidal1Cytokines1Ketorolac1Multiple Trauma1
Journals, researchers & institutions
Top journals
  • Journal of orthopaedic trauma2
Leading researchers
  • Aneja A2
  • Bernard AC2
  • Foster JA2
  • Griffin JT2
  • Hawk GS2
  • Landy DC2
  • Oyler DR2
  • Borgida JS1
Leading institutions
free-text, unnormalised
  • University of Kentucky2
  • Massachusetts General Hospital1
  • OrthoVirginia and Liberty University1
  • US Army Institute of Surgical Research1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials